Dynavax Technologies (DVAX)
(Delayed Data from NSDQ)
$11.15 USD
+0.01 (0.09%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $11.14 -0.01 (-0.09%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth NA Momentum NA VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DVAX 11.15 +0.01(0.09%)
Will DVAX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DVAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DVAX
Exelixis (EXEL) Beats Q2 Earnings Estimates
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why
DVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates
GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP
Other News for DVAX
Deep Track Capital, LP Increases Stake in Tarsus Pharmaceuticals Inc
Dynavax Technologies Corp (DVAX) Announces Q2 2025 Financial Results Release and Conference ...
Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, ...
Wolverine Asset Management LLC Increases Stake in Future Vision II Acquisition Corp
WOLVERINE ASSET MANAGEMENT LLC Increases Stake in Agriculture & Natural Solutions ...